1. Home
  2. CCEP vs EW Comparison

CCEP vs EW Comparison

Compare CCEP & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coca-Cola Europacific Partners plc

CCEP

Coca-Cola Europacific Partners plc

HOLD

Current Price

$96.50

Market Cap

44.9B

ML Signal

HOLD

Logo Edwards Lifesciences Corporation

EW

Edwards Lifesciences Corporation

HOLD

Current Price

$78.05

Market Cap

50.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCEP
EW
Founded
1986
1958
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Industrial Specialties
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.9B
50.2B
IPO Year
2015
1999

Fundamental Metrics

Financial Performance
Metric
CCEP
EW
Price
$96.50
$78.05
Analyst Decision
Buy
Buy
Analyst Count
6
21
Target Price
$105.83
$96.21
AVG Volume (30 Days)
1.9M
4.1M
Earning Date
02-17-2026
04-23-2026
Dividend Yield
2.42%
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.83
Revenue
N/A
$6,067,600,000.00
Revenue This Year
$4.76
$13.39
Revenue Next Year
$3.82
$9.81
P/E Ratio
$20.93
$42.69
Revenue Growth
N/A
11.55
52 Week Low
$84.66
$68.63
52 Week High
$110.90
$87.89

Technical Indicators

Market Signals
Indicator
CCEP
EW
Relative Strength Index (RSI) 50.97 38.09
Support Level $89.03 $77.60
Resistance Level $100.67 $78.64
Average True Range (ATR) 1.95 1.96
MACD 0.65 -0.33
Stochastic Oscillator 71.22 15.32

Price Performance

Historical Comparison
CCEP
EW

About CCEP Coca-Cola Europacific Partners plc

CCEP is the second-largest bottling partner in the Coca-Cola system by volume, behind Coca-Cola Femsa, and primarily operates in developed Europe, Australasia, and Southeast Asia. In 2025, CCEP sold 3.9 billion unit cases of beverages, which we estimate equates to roughly 9% of the global Coke system volume.TCCC owns 19% of the equity of CCEP, Olive Partners, a holding company of bottling operations, owns a further 36%, and the remaining 45% is free float.

About EW Edwards Lifesciences Corporation

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

Share on Social Networks: